Corona Remedies IPO vs Wakefit Innovations IPO vs Nephrocare IPO: What does GMP signal about listing pop? – livemint.com

Share

Share

Share

Share

Email

Comments

1. Corona Remedies IPO vs Wakefit Innovations IPO vs Nephrocare IPO: What does GMP signal about listing pop?  livemint.com
2. Corona Remedies IPO: Issue subscribed 144 times on Day 03; NII, QIB portions see huge demand, GMP signals 25% premium  livemint.com
3. Corona Remedies IPO Day 3: Check Latest GMP, Subscription Status & Key Highlights  Groww
4. Corona Remedies IPO vs Wakefit Innovations IPO vs Nephrocare IPO: What GMP signals about listing pop?  MSN
5. Corona Remedies IPO Live Update : Potential Surveillance Measures Post-Listing  The Economic Times